Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FHVUG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,652
Award facts
- Contract value 100% obligated
- $14,651.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) valued at $14,651.57 under a firm fixed-price contract type. The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates its capability to meet federal procurement requirements through open competition, delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Gemtesa, a medication used in the treatment of overactive bladder, exemplifies the company's role in providing essential pharmaceutical commodities to support Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DB26FHVUG?
SPE2DB26FHVUG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FHVUG worth?
The government has obligated $14,652 on SPE2DB26FHVUG.
Is contract SPE2DB26FHVUG an order under another contract?
Yes. SPE2DB26FHVUG is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB26FHVUG competed?
The extent of competition for SPE2DB26FHVUG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award